1. NanoVibronix inks deal with Indian regulatory and distribution consultant
NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory and marketing partner in India. Morulaa HealthTech will help bring NanoVibronix’s products to India, including its UroShield, WoundShield and PainShield. Morulaa HealthTech also has an in-house regulatory team and an established third-party distribution network across India in both rural and urban areas.
2. K2M wins CE Mark for Capri cervical cage
K2M has received CE Mark for its Capri Cervical 3D Expandable Corpectomy Cage System with Lamellar 3D Titanium Technology, according to a Dec. 20 press release. The Capri Cervical 3D Expandable is the first and only 3D-printed expandable device on the market that helps with in-situ height expansion and endplate angulation in the cervical spine. K2M’s cage system also stabilizes the cervical spine in vertebral body resections that happen from trauma or tumor.
3. China clears Impulse Dynamic’s Optimizer cardiac failure device
Impulse Dynamics announced in a Dec. 18 press release that the China Food and Drug Administration has approved its Optimizer system for treatment of chronic heart failure. The device delivers non-excitatory Cardiac Contractility Modulation signals to the heart to help create multiple biochemical and neurohormonal changes to the myocardium. The myocardium contractility increase and causes no concomitant increase in oxygen consumption which allows for the heart to work more efficiently.
4. NeuX inks neuromuscular strain prevention deal with Muscle Activation Technique
NeuX Technologies and Muscle Activation Technique have forged a strategic alliance to develop solutions for treating and preventing musculoskeletal conditions, according to a Dec. 14 press release. The partnership will help with musculoskeletal conditions that result in chronic pain, limited range of motion and less than optimal performance in daily and athletic activities.
5. Guided Therapeutics inks Turkish distro deal
Guided Therapeutics announced in a Dec. 8 press release that it has signed a distribution agreement with Turkish distributor ITEM for the manufacture of its single-patient-use Cervical Guides in Turkey. ITEM will hold licensing and manufacturing rights for Guided Therapeutics’s Cervical Guides in Turkey and Guided Therapeutics will receive fees of $3M in 2018. Guided Therapeutics will also receive a royalty for each device sold in Turkey.